ArticleLeukemia2017

The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases.

A Stengel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.